Kintegral Advisory’s Elevance Health ELV Stock Holding History

Kintegral Advisory’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,070	Closed	-$1.4M	–	280
2022 Q3	$1.4M	Hold	3,070	–	–	0.19%	123
2022 Q2	$1.48M	Buy	3,070 +65	+2%	+$32.2K	0.19%	122
2022 Q1	$1.48M	Buy	3,005 +67	+2%	+$30.6K	0.16%	131
2021 Q4	$1.36M	Hold	2,938	–	–	0.14%	137
2021 Q3	$1.09M	Hold	2,938	–	–	0.13%	144
2021 Q2	$1.12M	Hold	2,938	–	–	0.13%	142
2021 Q1	$1.05M	Hold	2,938	–	–	0.14%	142
2020 Q4	$943K	Hold	2,938	–	–	0.13%	151
2020 Q3	$789K	Sell	2,938 -95	-3%	-$25.6K	0.12%	150
2020 Q2	$798K	Hold	3,033	–	–	0.13%	143
2020 Q1	$689K	Buy	3,033 +339	+13%	+$92.4K	0.13%	139
2019 Q4	$814K	Hold	2,694	–	–	0.15%	144
2019 Q3	$647K	Hold	2,694	–	–	0.13%	154
2019 Q2	$760K	Hold	2,694	–	–	0.15%	142
2019 Q1	$773K	Buy	2,694 +27	+1%	+$7.81K	0.16%	141
2018 Q4	$700K	Buy	+2,667	New	+$733K	0.21%	109

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Kintegral Advisory's ELV Position: Q4 2022 in Review

Kintegral Advisory sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 3,070 shares — an estimated $1.4M sold.

Kintegral Advisory first reported a position in ELV in Q4 2018 and held it in 16 quarters. The position peaked at $1.48M in Q2 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Kintegral Advisory reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
Kintegral Advisory sold 3,070 Elevance Health shares in Q4 2022, an estimated $1.4M.
Kintegral Advisory first reported a position in Elevance Health in Q4 2018 and held it in 16 quarters.
Kintegral Advisory's Elevance Health position peaked at $1.48M in Q2 2022.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Kintegral Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.